Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Income from Continuing Operations (2017 - 2025)

Catheter Precision (VTAK) has disclosed Income from Continuing Operations for 9 consecutive years, with 592000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 85.63% to 592000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 15930000.0, a 36.34% decrease, with the full-year FY2024 number at 13502000.0, up 80.87% from a year prior.
  • Income from Continuing Operations was 592000.0 for Q3 2025 at Catheter Precision, up from 8082000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 592000.0 in Q3 2025 to a low of 66400000.0 in Q1 2023.
  • A 5-year average of 8008894.74 and a median of 4769000.0 in 2025 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: plummeted 1108.37% in 2023, then soared 95.97% in 2024.
  • Catheter Precision's Income from Continuing Operations stood at 8283000.0 in 2021, then rose by 1.5% to 8159000.0 in 2022, then soared by 91.8% to 669000.0 in 2023, then plummeted by 271.75% to 2487000.0 in 2024, then soared by 76.2% to 592000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Income from Continuing Operations are 592000.0 (Q3 2025), 8082000.0 (Q2 2025), and 4769000.0 (Q1 2025).